0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Repair PARP Inhibitor Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19G15182
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global DNA Repair PARP Inhibitor Market Research Report 2023
BUY CHAPTERS

Global DNA Repair PARP Inhibitor Market Research Report 2025

Code: QYRE-Auto-19G15182
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

DNA Repair PARP Inhibitor Market

The global market for DNA Repair PARP Inhibitor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for DNA Repair PARP Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for DNA Repair PARP Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of DNA Repair PARP Inhibitor include AstraZeneca plc, Clovis Oncology, Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline plc, Bristol Myers Squibb Company, Onxeo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DNA Repair PARP Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Repair PARP Inhibitor.
The DNA Repair PARP Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Repair PARP Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Repair PARP Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DNA Repair PARP Inhibitor Market Report

Report Metric Details
Report Name DNA Repair PARP Inhibitor Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca plc, Clovis Oncology, Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline plc, Bristol Myers Squibb Company, Onxeo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of DNA Repair PARP Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of DNA Repair PARP Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the DNA Repair PARP Inhibitor Market report?

Ans: The main players in the DNA Repair PARP Inhibitor Market are AstraZeneca plc, Clovis Oncology, Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline plc, Bristol Myers Squibb Company, Onxeo

What are the Application segmentation covered in the DNA Repair PARP Inhibitor Market report?

Ans: The Applications covered in the DNA Repair PARP Inhibitor Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the DNA Repair PARP Inhibitor Market report?

Ans: The Types covered in the DNA Repair PARP Inhibitor Market report are Tablets, Capsules, Injectables

Recommended Reports

Cancer Therapeutics

Targeted Therapies

Diagnostics & Genetic

1 DNA Repair PARP Inhibitor Market Overview
1.1 Product Definition
1.2 DNA Repair PARP Inhibitor by Type
1.2.1 Global DNA Repair PARP Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Injectables
1.3 DNA Repair PARP Inhibitor by Application
1.3.1 Global DNA Repair PARP Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global DNA Repair PARP Inhibitor Market Size Estimates and Forecasts
1.4.1 Global DNA Repair PARP Inhibitor Revenue 2020-2031
1.4.2 Global DNA Repair PARP Inhibitor Sales 2020-2031
1.4.3 Global DNA Repair PARP Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DNA Repair PARP Inhibitor Market Competition by Manufacturers
2.1 Global DNA Repair PARP Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global DNA Repair PARP Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global DNA Repair PARP Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DNA Repair PARP Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DNA Repair PARP Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DNA Repair PARP Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of DNA Repair PARP Inhibitor, Date of Enter into This Industry
2.8 Global DNA Repair PARP Inhibitor Market Competitive Situation and Trends
2.8.1 Global DNA Repair PARP Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest DNA Repair PARP Inhibitor Players Market Share by Revenue
2.8.3 Global DNA Repair PARP Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DNA Repair PARP Inhibitor Market Scenario by Region
3.1 Global DNA Repair PARP Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DNA Repair PARP Inhibitor Sales by Region: 2020-2031
3.2.1 Global DNA Repair PARP Inhibitor Sales by Region: 2020-2025
3.2.2 Global DNA Repair PARP Inhibitor Sales by Region: 2026-2031
3.3 Global DNA Repair PARP Inhibitor Revenue by Region: 2020-2031
3.3.1 Global DNA Repair PARP Inhibitor Revenue by Region: 2020-2025
3.3.2 Global DNA Repair PARP Inhibitor Revenue by Region: 2026-2031
3.4 North America DNA Repair PARP Inhibitor Market Facts & Figures by Country
3.4.1 North America DNA Repair PARP Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DNA Repair PARP Inhibitor Sales by Country (2020-2031)
3.4.3 North America DNA Repair PARP Inhibitor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe DNA Repair PARP Inhibitor Market Facts & Figures by Country
3.5.1 Europe DNA Repair PARP Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DNA Repair PARP Inhibitor Sales by Country (2020-2031)
3.5.3 Europe DNA Repair PARP Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DNA Repair PARP Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific DNA Repair PARP Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DNA Repair PARP Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific DNA Repair PARP Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America DNA Repair PARP Inhibitor Market Facts & Figures by Country
3.7.1 Latin America DNA Repair PARP Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DNA Repair PARP Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America DNA Repair PARP Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DNA Repair PARP Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa DNA Repair PARP Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DNA Repair PARP Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa DNA Repair PARP Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DNA Repair PARP Inhibitor Sales by Type (2020-2031)
4.1.1 Global DNA Repair PARP Inhibitor Sales by Type (2020-2025)
4.1.2 Global DNA Repair PARP Inhibitor Sales by Type (2026-2031)
4.1.3 Global DNA Repair PARP Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global DNA Repair PARP Inhibitor Revenue by Type (2020-2031)
4.2.1 Global DNA Repair PARP Inhibitor Revenue by Type (2020-2025)
4.2.2 Global DNA Repair PARP Inhibitor Revenue by Type (2026-2031)
4.2.3 Global DNA Repair PARP Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global DNA Repair PARP Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global DNA Repair PARP Inhibitor Sales by Application (2020-2031)
5.1.1 Global DNA Repair PARP Inhibitor Sales by Application (2020-2025)
5.1.2 Global DNA Repair PARP Inhibitor Sales by Application (2026-2031)
5.1.3 Global DNA Repair PARP Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global DNA Repair PARP Inhibitor Revenue by Application (2020-2031)
5.2.1 Global DNA Repair PARP Inhibitor Revenue by Application (2020-2025)
5.2.2 Global DNA Repair PARP Inhibitor Revenue by Application (2026-2031)
5.2.3 Global DNA Repair PARP Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global DNA Repair PARP Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca plc
6.1.1 AstraZeneca plc Company Information
6.1.2 AstraZeneca plc Description and Business Overview
6.1.3 AstraZeneca plc DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca plc DNA Repair PARP Inhibitor Product Portfolio
6.1.5 AstraZeneca plc Recent Developments/Updates
6.2 Clovis Oncology
6.2.1 Clovis Oncology Company Information
6.2.2 Clovis Oncology Description and Business Overview
6.2.3 Clovis Oncology DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Clovis Oncology DNA Repair PARP Inhibitor Product Portfolio
6.2.5 Clovis Oncology Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Company Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Inc. DNA Repair PARP Inhibitor Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Merck & Co. Inc.
6.4.1 Merck & Co. Inc. Company Information
6.4.2 Merck & Co. Inc. Description and Business Overview
6.4.3 Merck & Co. Inc. DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck & Co. Inc. DNA Repair PARP Inhibitor Product Portfolio
6.4.5 Merck & Co. Inc. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG DNA Repair PARP Inhibitor Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson DNA Repair PARP Inhibitor Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.7.1 GlaxoSmithKline plc Company Information
6.7.2 GlaxoSmithKline plc Description and Business Overview
6.7.3 GlaxoSmithKline plc DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline plc DNA Repair PARP Inhibitor Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 Bristol Myers Squibb Company
6.8.1 Bristol Myers Squibb Company Company Information
6.8.2 Bristol Myers Squibb Company Description and Business Overview
6.8.3 Bristol Myers Squibb Company DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol Myers Squibb Company DNA Repair PARP Inhibitor Product Portfolio
6.8.5 Bristol Myers Squibb Company Recent Developments/Updates
6.9 Onxeo
6.9.1 Onxeo Company Information
6.9.2 Onxeo Description and Business Overview
6.9.3 Onxeo DNA Repair PARP Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Onxeo DNA Repair PARP Inhibitor Product Portfolio
6.9.5 Onxeo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DNA Repair PARP Inhibitor Industry Chain Analysis
7.2 DNA Repair PARP Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DNA Repair PARP Inhibitor Production Mode & Process Analysis
7.4 DNA Repair PARP Inhibitor Sales and Marketing
7.4.1 DNA Repair PARP Inhibitor Sales Channels
7.4.2 DNA Repair PARP Inhibitor Distributors
7.5 DNA Repair PARP Inhibitor Customer Analysis
8 DNA Repair PARP Inhibitor Market Dynamics
8.1 DNA Repair PARP Inhibitor Industry Trends
8.2 DNA Repair PARP Inhibitor Market Drivers
8.3 DNA Repair PARP Inhibitor Market Challenges
8.4 DNA Repair PARP Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global DNA Repair PARP Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global DNA Repair PARP Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global DNA Repair PARP Inhibitor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global DNA Repair PARP Inhibitor Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global DNA Repair PARP Inhibitor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global DNA Repair PARP Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global DNA Repair PARP Inhibitor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market DNA Repair PARP Inhibitor Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of DNA Repair PARP Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of DNA Repair PARP Inhibitor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of DNA Repair PARP Inhibitor, Product Type & Application
 Table 12. Global Key Manufacturers of DNA Repair PARP Inhibitor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global DNA Repair PARP Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Repair PARP Inhibitor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global DNA Repair PARP Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global DNA Repair PARP Inhibitor Sales by Region (2020-2025) & (K Units)
 Table 18. Global DNA Repair PARP Inhibitor Sales Market Share by Region (2020-2025)
 Table 19. Global DNA Repair PARP Inhibitor Sales by Region (2026-2031) & (K Units)
 Table 20. Global DNA Repair PARP Inhibitor Sales Market Share by Region (2026-2031)
 Table 21. Global DNA Repair PARP Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global DNA Repair PARP Inhibitor Revenue Market Share by Region (2020-2025)
 Table 23. Global DNA Repair PARP Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global DNA Repair PARP Inhibitor Revenue Market Share by Region (2026-2031)
 Table 25. North America DNA Repair PARP Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America DNA Repair PARP Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 27. North America DNA Repair PARP Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 28. North America DNA Repair PARP Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America DNA Repair PARP Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe DNA Repair PARP Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe DNA Repair PARP Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 32. Europe DNA Repair PARP Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 33. Europe DNA Repair PARP Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe DNA Repair PARP Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific DNA Repair PARP Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific DNA Repair PARP Inhibitor Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific DNA Repair PARP Inhibitor Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific DNA Repair PARP Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific DNA Repair PARP Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA Repair PARP Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America DNA Repair PARP Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America DNA Repair PARP Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America DNA Repair PARP Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America DNA Repair PARP Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa DNA Repair PARP Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa DNA Repair PARP Inhibitor Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa DNA Repair PARP Inhibitor Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa DNA Repair PARP Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa DNA Repair PARP Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global DNA Repair PARP Inhibitor Sales (K Units) by Type (2020-2025)
 Table 51. Global DNA Repair PARP Inhibitor Sales (K Units) by Type (2026-2031)
 Table 52. Global DNA Repair PARP Inhibitor Sales Market Share by Type (2020-2025)
 Table 53. Global DNA Repair PARP Inhibitor Sales Market Share by Type (2026-2031)
 Table 54. Global DNA Repair PARP Inhibitor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global DNA Repair PARP Inhibitor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global DNA Repair PARP Inhibitor Revenue Market Share by Type (2020-2025)
 Table 57. Global DNA Repair PARP Inhibitor Revenue Market Share by Type (2026-2031)
 Table 58. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Type (2020-2025)
 Table 59. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Type (2026-2031)
 Table 60. Global DNA Repair PARP Inhibitor Sales (K Units) by Application (2020-2025)
 Table 61. Global DNA Repair PARP Inhibitor Sales (K Units) by Application (2026-2031)
 Table 62. Global DNA Repair PARP Inhibitor Sales Market Share by Application (2020-2025)
 Table 63. Global DNA Repair PARP Inhibitor Sales Market Share by Application (2026-2031)
 Table 64. Global DNA Repair PARP Inhibitor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global DNA Repair PARP Inhibitor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global DNA Repair PARP Inhibitor Revenue Market Share by Application (2020-2025)
 Table 67. Global DNA Repair PARP Inhibitor Revenue Market Share by Application (2026-2031)
 Table 68. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Application (2020-2025)
 Table 69. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca plc Company Information
 Table 71. AstraZeneca plc Description and Business Overview
 Table 72. AstraZeneca plc DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca plc DNA Repair PARP Inhibitor Product
 Table 74. AstraZeneca plc Recent Developments/Updates
 Table 75. Clovis Oncology Company Information
 Table 76. Clovis Oncology Description and Business Overview
 Table 77. Clovis Oncology DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Clovis Oncology DNA Repair PARP Inhibitor Product
 Table 79. Clovis Oncology Recent Developments/Updates
 Table 80. Pfizer Inc. Company Information
 Table 81. Pfizer Inc. Description and Business Overview
 Table 82. Pfizer Inc. DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Inc. DNA Repair PARP Inhibitor Product
 Table 84. Pfizer Inc. Recent Developments/Updates
 Table 85. Merck & Co. Inc. Company Information
 Table 86. Merck & Co. Inc. Description and Business Overview
 Table 87. Merck & Co. Inc. DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck & Co. Inc. DNA Repair PARP Inhibitor Product
 Table 89. Merck & Co. Inc. Recent Developments/Updates
 Table 90. Novartis AG Company Information
 Table 91. Novartis AG Description and Business Overview
 Table 92. Novartis AG DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis AG DNA Repair PARP Inhibitor Product
 Table 94. Novartis AG Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson DNA Repair PARP Inhibitor Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. GlaxoSmithKline plc Company Information
 Table 101. GlaxoSmithKline plc Description and Business Overview
 Table 102. GlaxoSmithKline plc DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline plc DNA Repair PARP Inhibitor Product
 Table 104. GlaxoSmithKline plc Recent Developments/Updates
 Table 105. Bristol Myers Squibb Company Company Information
 Table 106. Bristol Myers Squibb Company Description and Business Overview
 Table 107. Bristol Myers Squibb Company DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bristol Myers Squibb Company DNA Repair PARP Inhibitor Product
 Table 109. Bristol Myers Squibb Company Recent Developments/Updates
 Table 110. Onxeo Company Information
 Table 111. Onxeo Description and Business Overview
 Table 112. Onxeo DNA Repair PARP Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Onxeo DNA Repair PARP Inhibitor Product
 Table 114. Onxeo Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. DNA Repair PARP Inhibitor Distributors List
 Table 118. DNA Repair PARP Inhibitor Customers List
 Table 119. DNA Repair PARP Inhibitor Market Trends
 Table 120. DNA Repair PARP Inhibitor Market Drivers
 Table 121. DNA Repair PARP Inhibitor Market Challenges
 Table 122. DNA Repair PARP Inhibitor Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of DNA Repair PARP Inhibitor
 Figure 2. Global DNA Repair PARP Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA Repair PARP Inhibitor Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Capsules Product Picture
 Figure 6. Injectables Product Picture
 Figure 7. Global DNA Repair PARP Inhibitor Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global DNA Repair PARP Inhibitor Market Share by Application: 2024 & 2031
 Figure 9. Retail Pharmacies
 Figure 10. Hospital Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Global DNA Repair PARP Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global DNA Repair PARP Inhibitor Market Size (2020-2031) & (US$ Million)
 Figure 14. Global DNA Repair PARP Inhibitor Sales (2020-2031) & (K Units)
 Figure 15. Global DNA Repair PARP Inhibitor Average Price (US$/Unit) & (2020-2031)
 Figure 16. DNA Repair PARP Inhibitor Report Years Considered
 Figure 17. DNA Repair PARP Inhibitor Sales Share by Manufacturers in 2024
 Figure 18. Global DNA Repair PARP Inhibitor Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest DNA Repair PARP Inhibitor Players: Market Share by Revenue in DNA Repair PARP Inhibitor in 2024
 Figure 20. DNA Repair PARP Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global DNA Repair PARP Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America DNA Repair PARP Inhibitor Sales Market Share by Country (2020-2031)
 Figure 23. North America DNA Repair PARP Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 24. United States DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe DNA Repair PARP Inhibitor Sales Market Share by Country (2020-2031)
 Figure 27. Europe DNA Repair PARP Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 28. Germany DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific DNA Repair PARP Inhibitor Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific DNA Repair PARP Inhibitor Revenue Market Share by Region (2020-2031)
 Figure 35. China DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America DNA Repair PARP Inhibitor Sales Market Share by Country (2020-2031)
 Figure 43. Latin America DNA Repair PARP Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa DNA Repair PARP Inhibitor Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa DNA Repair PARP Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE DNA Repair PARP Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of DNA Repair PARP Inhibitor by Type (2020-2031)
 Figure 53. Global Revenue Market Share of DNA Repair PARP Inhibitor by Type (2020-2031)
 Figure 54. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of DNA Repair PARP Inhibitor by Application (2020-2031)
 Figure 56. Global Revenue Market Share of DNA Repair PARP Inhibitor by Application (2020-2031)
 Figure 57. Global DNA Repair PARP Inhibitor Price (US$/Unit) by Application (2020-2031)
 Figure 58. DNA Repair PARP Inhibitor Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart